Volitionrx Stock Today
| VNRX Stock | USD 0.79 0.02 2.47% |
Performance6 of 100
| Odds Of DistressOver 78
|
Volitionrx is trading at 0.79 as of the 25th of November 2024; that is 2.47 percent decrease since the beginning of the trading day. The stock's open price was 0.81. Volitionrx has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Volitionrx are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of December 2023 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 25th of April 2007 | Category Healthcare | Classification Health Care |
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. The company operates Nucleosomics a technology platform for blood test. Volitionrx operates under Diagnostics Research classification in the United States and is traded on AMEX Exchange. The company has 92.66 M outstanding shares of which 441.92 K shares are at this time shorted by private and institutional investors with about 3.71 trading days to cover. More on Volitionrx
Moving against Volitionrx Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Volitionrx Stock Highlights
| Executive Chairman | Martin Faulkes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Pharmaceutical Products (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Pharmaceutical Products, Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsVolitionrx can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Volitionrx's financial leverage. It provides some insight into what part of Volitionrx's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Volitionrx (VNRX) is traded on NYSE MKT Exchange in USA. It is located in 1489 West Warm Springs Road, Henderson, NV, United States, 89014 and employs 101 people. Volitionrx is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 73.57 M. Volitionrx conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 92.66 M outstanding shares of which 441.92 K shares are at this time shorted by private and institutional investors with about 3.71 trading days to cover.
Volitionrx currently holds about 16.42 M in cash with (18.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28.
Check Volitionrx Probability Of Bankruptcy
Ownership AllocationVolitionrx shows a total of 92.66 Million outstanding shares. Volitionrx maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Volitionrx Ownership Details
Volitionrx Historical Income Statement
Volitionrx Stock Against Markets
Volitionrx Corporate Management
| Salvatore DVM | Chief LLC | Profile | |
| Scott Powell | Executive Relations | Profile | |
| Gael MBA | Chief Officer | Profile | |
| Gaetan Michel | Chief Officer | Profile | |
| Louise Day | Chief Officer | Profile | |
| Jacob MBA | Chief Officer | Profile |
Additional Tools for Volitionrx Stock Analysis
When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.